loadpatents
Patent applications and USPTO patent grants for AMITECH THERAPEUTIC SOLUTIONS, INC..The latest application filed is for "therapeutic methods and compositions involving allosteric kinase inhibition".
Patent | Date |
---|---|
Heterocyclic compounds useful for kinase inhibition Grant 10,214,513 - Arnold , et al. Feb | 2019-02-26 |
Therapeutic Methods And Compositions Involving Allosteric Kinase Inhibition App 20160237064 - MURPHY; Eric A. ;   et al. | 2016-08-18 |
Heterocyclic Compounds Useful for Kinase Inhibition App 20160096824 - ARNOLD; Lee Daniel ;   et al. | 2016-04-07 |
Therapeutic methods and compositions involving allosteric kinase inhibition Grant 9,260,417 - Murphy , et al. February 16, 2 | 2016-02-16 |
Heterocyclic compounds useful for kinase inhibition Grant 9,212,151 - Arnold , et al. December 15, 2 | 2015-12-15 |
Heterocyclic Compounds Useful for Kinase Inhibition App 20150158828 - ARNOLD; Lee Daniel ;   et al. | 2015-06-11 |
Heterocyclic compounds useful for kinase inhibition Grant 8,957,216 - Arnold , et al. February 17, 2 | 2015-02-17 |
Heterocyclic Compounds Useful For Kinase Inhibition App 20130123284 - Arnold; Lee Daniel ;   et al. | 2013-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.